Xeris Biopharma Holdings, Inc.
Status: Publicly traded
Direct answer
Xeris Biopharma Holdings, Inc. is publicly traded on NASDAQ under the ticker XERS.
Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology. Its current portfolio includes: Gvoke: A ready-to-administer liquid glucagon designed to treat severe hypoglycemia. Keveyis: A therapy addressing hyperkalemic, hypokalemic, and related...
Can you invest in Xeris Biopharma Holdings, Inc.?
Yes. Xeris Biopharma Holdings, Inc. trades publicly on NASDAQ as XERS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Xeris Biopharma Holdings, Inc.
Detailed equity research is provided by MarketSnap.